Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of IDX719 in Healthy and HCV-Infected Subjects
NCT01508156Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2012
- Primary completion
- Jul 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of samatasvir in chronic hepatitis C (CHC), sponsored by Merck & Co.. Started Jan 2012; status: completed.
02
Drugs
samatasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT01508156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01508156.